Alpha-Gal Syndrome PBMC

All filters

Format

Format

Format
Volume / Size

Volume / Size

Volume / Size
Condition

Condition

Condition

Start typing to see matching condition.

Donor Demographics

Donor Demographics

Gender
Age Range
Race / Ethnicity

Start typing to see matching race / ethnicity.

Country of Collection
Medical History

Medical History

Medications

Start typing to see matching medications.

Comorbidities

Start typing to see matching comorbidities.

Allergy List

Start typing to see matching allergy list.

Lab Results, HLA, & Testing

Lab Results, HLA, & Testing

HLA Typing
HLA-A
HLA-B
HLA-C
HLA-DRB1
HLA-DRB4
HLA-DQA1
HLA-DQB1
HLA-DPA1
HLA-DPB1
ABO Type
Rh Type
CMV Status
HIV/HBV/HCV Tested
Syphilis Tested
Flow Data

Flow Data

Has Flow Data
Viable CD45+ (% of singlets)
CD3+ T cells (% of viable CD45+)
CD4+CD8− (% of viable CD45+)
CD4−CD8+ (% of viable CD45+)
CD3−CD16/56+ NK (% of viable CD45+)
CD19+ B cells (% of viable CD45+)
CD14+ monocytes (% of viable CD45+)
Lifestyle

Lifestyle

Tobacco Use
Alcohol Use
Recreational Drug Use
Caffeine Use
Find by ID

Find by ID

Lot #

Start typing to see matching lot #.

Patient ID

Start typing to see matching patient id.

5 lots match
5 lots available
Specimen IDSample TypeBag SizeCells / VolumePrimary DiseaseDiagnosisAllergiesAllergy ListHas Food AllergiesBMICMV StatusHIV/HBV/HCV TestedSyphilis TestedHas Infectious DiseaseInfectious DiseaseTobacco UseYears of SmokingPacks per DayAlcohol UseRecreational Drug UseCaffeine UseABO TypeRh TypeViable CD45+ (% of singlets)CD3+ T cells (% of viable CD45+)CD4+CD8− (% of viable CD45+)CD4−CD8+ (% of viable CD45+)CD3−CD16/56+ NK (% of viable CD45+)CD19+ B cells (% of viable CD45+)CD14+ monocytes (% of viable CD45+)Sample StatusAvailability
Alpha-Gal Syndrome (AGS) PBMC 68262 129558 Female 18-30 Caucasian Cryopreserved 1 mL 10 10M zoely birth control albuterol, PRN vitamin D supplement iron supplement Alpha-Gal Syndrome (AGS) United States 2025 — — — — — — — — — 150411; 150412; 150413; 150414; 150415; 150416; 150417; 150418; 150419; 150420PBMC10M cellsAlpha-Gal Syndrome (AGS)Alpha-Gal Syndrome (AGS)Yesred meat, seasonal23.03NoNoNoNoYesNOYesStoredIn Stock
$530
Alpha-Gal Syndrome (AGS) PBMC 66639 130258 Male 46-60 Caucasian Cryopreserved 1 mL 2 10M B12/QOD Magnesium/QOD Zinc/QOD Potassium Citrate Vitamin C/QOD Lions mane/QOD Alpha-Gal Syndrome (AGS) United States 2025 — — — — — — — — — 144977; 144978PBMC10M cellsAlpha-Gal Syndrome (AGS)Alpha-Gal Syndrome (AGS)YesRed meat25.82NoNoNoNoNoNOYesStoredIn Stock
$530
Alpha-Gal Syndrome (AGS) PBMC 66675 129531 Male 61+ Caucasian Cryopreserved 1 mL 8 10M Klonidine 0.1 mg QD Valsartan/HCTZ 80/25 mg QD Atorvastatin 40 mg QD Metoprolol 100 mg QD Alpha-Gal Syndrome (AGS) United States 2025 — — — — — — — — — 143893; 143894; 143895; 143896; 143897; 143898; 143899; 143900PBMC10M cellsAlpha-Gal Syndrome (AGS)Alpha-Gal Syndrome (AGS)No31.01NoNoNoYes-Currently Smokes300.5YesNOYesStoredIn Stock
$530
Alpha-Gal Syndrome (AGS) PBMC 66839 129422 Male 31-45 Caucasian Cryopreserved 1 mL 4 10M Sertraline 50 mg QD Zyrtec 20 mg BID Epi Pen PRN Pepcid 20 mg BID Singulair 10 mg QD Ativan 0.5 mg PRN Alpha-Gal Syndrome (AGS) United States 2025 — — — — — — — — — 144347; 144348; 144349; 144350PBMC10M cellsAlpha-Gal Syndrome (AGS)Alpha-Gal Syndrome (AGS)YesMeat22.96NoNoNoNoNoNONoStoredIn Stock
$530
Alpha-Gal Syndrome (AGS) PBMC 66721 128332 Female 31-45 Caucasian Cryopreserved 1 mL 3 10M — Alpha-Gal Syndrome (AGS) United States 2025 — — — — — — — — — 144289; 144290; 144291PBMC10M cellsAlpha-Gal Syndrome (AGS)Alpha-Gal Syndrome (AGS)No18.79NoNoNoUsed to Smoke81NoNONoStoredIn Stock
$530

Showing 1–5 of 5 lots

About Alpha-Gal Syndrome PBMC

Alpha-Gal Syndrome PBMC are sourced from consented donors with documented alpha-gal syndrome (AGS). These samples support allergic disease and type 2 immunity research, with donor information on condition, demographics, medications and comorbidities.

Applications

  • Allergic disease and type 2 immunity research
  • Immune-cell phenotyping
  • Cellular functional assays
  • Single-cell and bulk transcriptomics
  • Drug-response research

Product Features

  • Peripheral blood mononuclear cells
  • Donor condition: Alpha-Gal Syndrome (AGS)
  • Consented donor collection
  • Research Use Only (RUO)

De-identified Donor Data

  • Donor condition/diagnosis and documented clinical phenotype
  • Age, gender and race/ethnicity
  • Medications and comorbidities
  • HLA typing and CMV status
  • HIV, HBV, HCV and syphilis testing
  • ABO/Rh blood type and country of collection
  • Tobacco, alcohol, caffeine and recreational drug use

Donor Stratification

Cohort characteristics include diagnosis and documented clinical phenotype, medication history, comorbidities and demographics.

Protocols & Documentation

  • PBMC Isolation from Whole Blood

    Standard operating procedure for isolating peripheral blood mononuclear cells from whole blood using density-gradient separation.

    Download
  • Immune Cell Isolation

    Guidelines for isolating immune cell populations with validated enrichment steps, purity checkpoints, and documentation.

    Download
  • Choosing the Right PBMC Configuration

    Reference guide comparing PBMC formats, cryopreservation states, and study-fit recommendations for your application.

    Download
  • Thawing Cryopreserved PBMC

    Validated thawing protocol to recover viable cryopreserved PBMCs while minimizing activation and loss of function.

    Download
  • Informed Consent Form (ICF)

    Available upon request — confirms donor consent for research use and downstream commercialization.

PBMC

Where can I find your complete catalog?
How long can samples be stored?

Storage depends on sample type but often cryopreserved samples stored in liquid nitrogen can be stored for years.

What customization options are available?

Extensive customization is available. To discuss your project request a quote or email us at learnmore@sanguinebio.com.

Do you offer prospective collections?

Sanguine offers flexible prospective collection services tailored to fit your research. For more information and to request a quote, please see: our prospective biospecimen collection services page.

What is the turnaround time for custom collections?

Timelines depend on condition, sample type, and I/E criteria but we often start collection within 2 weeks of signed agreement.

Do you have samples in stock?

YES - we have in-stock inventory. You can also email us at learnmore@sanguinebio.com as we continually get new samples in our inventory.

What does unique donor mean?

Each sample from a different individual - Unique donor means each sample comes from a different person, ensuring biological diversity in your study.

Are samples collected under IRB-approved protocols?

YES - "IRB-approved collection protocols" and IRB approval documentation available upon request. Sanguine utilizes two internationally-recognized IRBs (Advarra and WCG IRB) for review and approval.

Frequently Asked Questions

×

Ask a Question

Pair with a Healthy Control

Match your Alpha-Gal Syndrome PBMC with normal donor samples for comparison

Healthy Donor PBMCs

733 In Stock
Screened normal donors · Cryopreserved · Starting at $205
View Inventory

Need a custom PBMC cohort?

Our scientific team can scope prospective collections with donor-specific I/E criteria, typically starting within 2 weeks of agreement.

More Information